Dexamethasone as Abortive Treatment for Refractory Seizures or Status Epilepticus in the Inpatient Setting
Refractory seizures or status epilepticus (RS/SE) continues to be a challenge in the inpatient setting. Failure to abort a seizure with antiepileptic drugs (AEDs) may lead to intubation and treatment with general anesthesia exposing patients to complications, extending hospitalization, and increasin...
Main Authors: | Alexander B. Ramos MD, MS, Roberto A. Cruz MD, Nicole R. Villemarette-Pittman PhD, Piotr W. Olejniczak MD, PhD, Edward C. Mader MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-05-01
|
Series: | Journal of Investigative Medicine High Impact Case Reports |
Online Access: | https://doi.org/10.1177/2324709619848816 |
Similar Items
-
Typical Spike-and-Wave Activity in Hypoxic-Ischemic Brain Injury and its Implications for Classifying Nonconvulsive Status Epilepticus
by: Edward C. Mader Jr, et al.
Published: (2012-07-01) -
Cocaine-Associated Seizures and Incidence of Status Epilepticus
by: Majlesi, Nima DO, et al.
Published: (2010-05-01) -
Refractory Left Focal Motor Status Epilepticus as Initial Clinical Presentation of Acute Basilar Artery Thrombosis
by: Shubhang K. Bhatt, BS, et al.
Published: (2021-04-01) -
A PHASE 3, TWO-STAGE, RANDOMIZED STUDY OF MEZIGDOMIDE, CARFILZOMIB, AND DEXAMETHASONE (MEZIKD) VERSUS CARFILZOMIB AND DEXAMETHASONE (KD) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): SUCCESSOR-2
by: PGR Md, et al.
Published: (2023-10-01) -
Pulse Methylprednisolone Versus Dexamethasone in COVID-19: A Multicenter Cohort Study
by: Atsuyuki Watanabe, MD, et al.
Published: (2023-04-01)